Cargando…
Using a Fragment-Based Approach To Target Protein–Protein Interactions
The ability to identify inhibitors of protein–protein interactions represents a major challenge in modern drug discovery and in the development of tools for chemical biology. In recent years, fragment-based approaches have emerged as a new methodology in drug discovery; however, few examples of smal...
Autores principales: | Scott, Duncan E, Ehebauer, Matthias T, Pukala, Tara, Marsh, May, Blundell, Tom L, Venkitaraman, Ashok R, Abell, Chris, Hyvönen, Marko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
WILEY-VCH Verlag
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3594973/ https://www.ncbi.nlm.nih.gov/pubmed/23344974 http://dx.doi.org/10.1002/cbic.201200521 |
Ejemplares similares
-
Small-Molecule Inhibitors That Target Protein–Protein Interactions in the RAD51 Family of Recombinases
por: Scott, Duncan E, et al.
Publicado: (2015) -
ATP half‐sites in RadA and RAD51 recombinases bind nucleotides
por: Marsh, May E., et al.
Publicado: (2016) -
Structure‐activity relationship of the peptide binding‐motif mediating the BRCA2:RAD51 protein–protein interaction
por: Scott, Duncan E., et al.
Publicado: (2016) -
Engineering Archeal Surrogate Systems for the Development of Protein–Protein Interaction Inhibitors against Human RAD51
por: Moschetti, Tommaso, et al.
Publicado: (2016) -
A small-molecule inhibitor of the BRCA2-RAD51 interaction modulates RAD51 assembly and potentiates DNA damage-induced cell death
por: Scott, Duncan E., et al.
Publicado: (2021)